Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Summaries of opinion (11) Apply Summaries of opinion filter Withdrawn applications (26) Apply Withdrawn applications filter Referrals (6) Apply Referrals filter

Product number

Patient safety

Yes (5) Apply Yes filter

Authorisation status

Authorised (365) Apply Authorised filter Refused (3) Apply Refused filter Withdrawn (64) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (5) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (27) Apply PM: decision on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (9) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (4) Apply Yes filter

Compliance procedure number

Orphan disease / condition

Orphan decision number

Orphan designation status

Positive (40) Apply Positive filter

Medicine type

Accelerated assessment Remove Accelerated assessment filter Biosimilar Remove Biosimilar filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Additional monitoring (629) Apply Additional monitoring filter Conditional approval (79) Apply Conditional approval filter Orphan medicine (420) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

517 results

Remove all filtersRemove all filters

Categories Human Remove Human filter Veterinary Remove Veterinary filter

Medicine type Accelerated assessment Remove Accelerated assessment filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Biosimilar Remove Biosimilar filter

Medicine Orphan designations Remove Orphan designations filter Paediatric investigation plans Remove Paediatric investigation plans filter Direct healthcare professional communication Remove Direct healthcare professional communication filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter

Sort by

List item

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009, , Revision: 12, Authorised, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)

bortezomib, Multiple Myeloma
Date of authorisation: 14/11/2019, , Revision: 3, Authorised, Last updated: 18/01/2021
List item

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated)

busulfan, Hematopoietic Stem Cell Transplantation
Date of authorisation: 22/09/2014, , Revision: 8, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Grepid (updated)

clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 27/07/2009, , Revision: 21, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Lenvima (updated)

lenvatinib mesilate, Thyroid Neoplasms
Date of authorisation: 28/05/2015, , , Revision: 14, Authorised, Last updated: 15/01/2021
List item

Human medicine European public assessment report (EPAR): Kisplyx (updated)

lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016, , , Revision: 12, Authorised, Last updated: 14/01/2021
List item

Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)

zonisamide, Epilepsy
Date of authorisation: 31/03/2016, , Revision: 5, Authorised, Last updated: 14/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 23/09/2009, , Revision: 15, Authorised, Last updated: 13/01/2021
List item

Human medicine European public assessment report (EPAR): Foclivia (updated)

influenza virus surface antigens, inactivated: A/Viet Nam/1194/2004 (H5N1), Influenza, Human, Immunization, Disease Outbreaks
Date of authorisation: 18/10/2009, , Revision: 10, Authorised, Last updated: 13/01/2021
List item

Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)

daptomycin, Soft Tissue Infections, Skin Diseases, Bacterial
Date of authorisation: 22/03/2017, , Revision: 9, Authorised, Last updated: 08/01/2021
List item

Veterinary medicine European public assessment report (EPAR): Meloxidolor (updated)

meloxicam, Horses, Dogs, Cattle, Cats, Pigs
Date of authorisation: 22/04/2013, , Revision: 8, Authorised, Last updated: 07/01/2021
List item

Human medicine European public assessment report (EPAR): Blitzima (updated)

rituximab, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 13/07/2017, , , Revision: 9, Authorised, Last updated: 07/01/2021
List item

Human medicine European public assessment report (EPAR): Livogiva (updated)

teriparatide, Osteoporosis
Date of authorisation: 27/08/2020, , , Revision: 1, Authorised, Last updated: 07/01/2021
List item

Human medicine European public assessment report (EPAR): Zirabev (updated)

bevacizumab, Colorectal Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms
Date of authorisation: 14/02/2019, , , Revision: 7, Authorised, Last updated: 07/01/2021
List item

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

telmisartan, Hypertension
Date of authorisation: 29/09/2010, , Revision: 10, Authorised, Last updated: 05/01/2021
List item

Human medicine European public assessment report (EPAR): Erelzi (updated)

etanercept, Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid, Spondylitis, Ankylosing
Date of authorisation: 23/06/2017, , , Revision: 8, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Ofev (updated)

nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015, , Revision: 16, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Ontruzant (updated)

trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 15/11/2017, , , Revision: 7, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)

clopidogrel (as hydrogen sulfate), Acute Coronary Syndrome, Peripheral Vascular Diseases, Myocardial Infarction, Stroke
Date of authorisation: 27/07/2009, , Revision: 15, Authorised, Last updated: 04/01/2021
List item

Human medicine European public assessment report (EPAR): Hemlibra

Emicizumab, Hemophilia A
Date of authorisation: 23/02/2018, , , Revision: 7, Authorised, Last updated: 22/12/2020
List item

Human medicine European public assessment report (EPAR): Zytiga

abiraterone acetate, Prostatic Neoplasms
Date of authorisation: 05/09/2011, , Revision: 23, Authorised, Last updated: 21/12/2020
List item

Human medicine European public assessment report (EPAR): Idacio

adalimumab, Arthritis, Rheumatoid, Arthritis, Juvenile Rheumatoid, Psoriasis, Arthritis, Psoriatic, Spondylitis, Ankylosing, Uveitis, Hidradenitis Suppurativa, Colitis, Ulcerative, Crohn Disease
Date of authorisation: 02/04/2019, , , Revision: 5, Authorised, Last updated: 18/12/2020
List item

Human medicine European public assessment report (EPAR): Kalydeco

ivacaftor, Cystic Fibrosis
Date of authorisation: 23/07/2012, , , Revision: 26, Authorised, Last updated: 16/12/2020
List item

Human medicine European public assessment report (EPAR): Clopidogrel Mylan

clopidogrel (as hydrochloride), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 21/09/2009, , Revision: 16, Authorised, Last updated: 16/12/2020
List item

Human medicine European public assessment report (EPAR): Imvanex

modified vaccinia Ankara - Bavarian Nordic (MVA-BN) virus, Smallpox Vaccine
Date of authorisation: 31/07/2013, , , Revision: 18, Authorised, Last updated: 14/12/2020

Load more

517 results

Human medicine European public assessment report (EPAR): Clopidogrel TAD (updated)

Human medicine European public assessment report (EPAR): Bortezomib Fresenius Kabi (updated)

Human medicine European public assessment report (EPAR): Busulfan Fresenius Kabi (updated)

Human medicine European public assessment report (EPAR): Grepid (updated)

Human medicine European public assessment report (EPAR): Lenvima (updated)

Human medicine European public assessment report (EPAR): Kisplyx (updated)

Human medicine European public assessment report (EPAR): Zonisamide Mylan (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Krka (updated)

Human medicine European public assessment report (EPAR): Foclivia (updated)

Human medicine European public assessment report (EPAR): Daptomycin Hospira (updated)

Veterinary medicine European public assessment report (EPAR): Meloxidolor (updated)

Human medicine European public assessment report (EPAR): Blitzima (updated)

Human medicine European public assessment report (EPAR): Livogiva (updated)

Human medicine European public assessment report (EPAR): Zirabev (updated)

Human medicine European public assessment report (EPAR): Telmisartan Actavis (updated)

Human medicine European public assessment report (EPAR): Erelzi (updated)

Human medicine European public assessment report (EPAR): Ofev (updated)

Human medicine European public assessment report (EPAR): Ontruzant (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Teva (hydrogen sulphate) (updated)

Human medicine European public assessment report (EPAR): Hemlibra

Human medicine European public assessment report (EPAR): Zytiga

Human medicine European public assessment report (EPAR): Idacio

Human medicine European public assessment report (EPAR): Kalydeco

Human medicine European public assessment report (EPAR): Clopidogrel Mylan

Human medicine European public assessment report (EPAR): Imvanex